Skip to main content

Dr Reddys Laboratories Ltd

RDY
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001135951

No open-market purchases or sales by Dr Reddys Laboratories Ltd insiders were filed in the last 90 days; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.82B in total; no superinvestor holds it.

Superinvestors holding RDY, Q2 2026

See all superinvestors

No superinvestor reported holding RDY in Q2 2026.